Robert Gemmill (front, seated) and Dr. Patrick Nasarre (back), Medical University of South Carolina (IMAGE)

Medical University of South Carolina

Robert Gemmill (front, seated) and Dr. Patrick Nasarre (back), Medical University of South Carolina

Caption

Dr. Robert Gemmill (front, seated), Melvyn Berlinsky Endowed Chair for Cancer Research at the Medical University of South Carolina (MUSC), and Dr. Patrick Nasarre, an assistant professor in the College of Medicine at MUSC, are first and second authors on the Jan. 17, 2017 Science Signaling article showing that NRP2b uniquely supports TGF-beta-mediated lung cancer progression.

Credit

Medical University of South Carolina.

Usage Restrictions

Please provide credit line and correctly identify researchers

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.